These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20649950)

  • 1. The pharmaceutical death-ride of dihydroartemisinin.
    Jansen FH
    Malar J; 2010 Jul; 9():212. PubMed ID: 20649950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMV in partnership: the Eurartesim® experience.
    Ubben D; Poll EM
    Malar J; 2013 Jun; 12():211. PubMed ID: 23782869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple field assays to check quality of current artemisinin-based antimalarial combination formulations.
    Ioset JR; Kaur H
    PLoS One; 2009 Sep; 4(9):e7270. PubMed ID: 19789707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria and artemisinin derivatives: an updated review.
    Ansari MT; Saify ZS; Sultana N; Ahmad I; Saeed-Ul-Hassan S; Tariq I; Khanum M
    Mini Rev Med Chem; 2013 Nov; 13(13):1879-902. PubMed ID: 24070206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Dihydroartemisinin-Piperaquine Tablet Halves During Prolonged Storage Under Tropical Conditions.
    Hodel EM; Kaur H; Terlouw DJ
    Am J Trop Med Hyg; 2017 Feb; 96(2):338-340. PubMed ID: 27895269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development Insights of Surface Modified Lipid Nanoemulsions of Dihydroartemisinin for Malaria Chemotherapy: Characterization, and in vivo Antimalarial Evaluation.
    Umeyor CE; Obachie O; Chukwuka R; Attama A
    Recent Pat Biotechnol; 2019; 13(2):149-165. PubMed ID: 30514197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use.
    Tivura M; Asante I; van Wyk A; Gyaase S; Malik N; Mahama E; Hostetler DM; Fernandez FM; Asante KP; Kaur H; Owusu-Agyei S
    BMC Pharmacol Toxicol; 2016 Oct; 17(1):48. PubMed ID: 27788677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of anti-malarials collected in the private and informal sectors in Guyana and Suriname.
    Evans L; Coignez V; Barojas A; Bempong D; Bradby S; Dijiba Y; James M; Bretas G; Adhin M; Ceron N; Hinds-Semple A; Chibwe K; Lukulay P; Pribluda V
    Malar J; 2012 Jun; 11():203. PubMed ID: 22704709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-malarial market and policy surveys in sub-Saharan Africa.
    Diap G; Amuasi J; Boakye I; Sevcsik AM; Pecoul B
    Malar J; 2010 Apr; 9 Suppl 1(Suppl 3):S1. PubMed ID: 20423536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The malaria testing and treatment landscape in mainland Tanzania, 2016.
    ; Michael D; Mkunde SP
    Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicines for Malaria Venture: sustaining antimalarial drug development.
    Bathurst I; Hentschel C
    Trends Parasitol; 2006 Jul; 22(7):301-7. PubMed ID: 16757213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
    Foguim Tsombeng F; Gendrot M; Robert MG; Madamet M; Pradines B
    Malar J; 2019 Aug; 18(1):285. PubMed ID: 31443646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model.
    Patel K; Batty KT; Moore BR; Gibbons PL; Kirkpatrick CM
    J Antimicrob Chemother; 2014 Aug; 69(8):2155-63. PubMed ID: 24777899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review.
    Burger RJ; Visser BJ; Grobusch MP; van Vugt M
    Malar J; 2016 Feb; 15():99. PubMed ID: 26891915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New dimensions in the field of antimalarial research against malaria resurgence.
    Narula AK; Azad CS; Nainwal LM
    Eur J Med Chem; 2019 Nov; 181():111353. PubMed ID: 31525705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016.
    ; Musuva A; Ejersa W; Kiptui R; Memusi D; Abwao E
    Malar J; 2017 Dec; 16(1):494. PubMed ID: 29268789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.